Earl Baker

In October 2026, Earl Baker concentrated 70.86% of sales in Flower with year-over-year growth of 44.83% and month-over-month growth of 50.89%, while Pre-Roll held 16.92% share with a -14.74% year-over-year decline but a 54.25% month-over-month rebound. Vapor Pens accounted for 7.21% share with 29.02% year-over-year growth but a -3.72% month-over-month dip, and Concentrates reached 5.02% share with a 59.41% month-over-month lift off a small base. Against a brand-wide sales increase of 34.50% year over year and a 17.92% year-over-year reduction in average price to $19.59, the category mix signals that Flower’s outsized month-over-month surge, coupled with Pre-Roll’s short-term recovery, is pulling the portfolio toward value-leaning inhalables at the expense of steadier but smaller Vapor Pens momentum; the implication is a tactical shift into volume-heavy formats that can scale quickly.

With Flower ranked 13th in Connecticut and now contributing over 70% of sales, the 50.89% month-over-month expansion in that category, alongside a simultaneous 54.25% month-over-month lift in Pre-Roll, points to a push that prioritizes shelf coverage and price-accessible SKUs, while the -3.72% month-over-month contraction in Vapor Pens suggests constrained assortment or de-emphasis. The combination of a 44.83% year-over-year Flower rise and a -14.74% year-over-year Pre-Roll decline indicates that gains are concentrated where the brand has rank traction, implying a positioning anchored in Flower-led traffic capture that uses Pre-Roll as a complementary entry point rather than a growth engine.